
From survodutide titration to oral PCSK9 adherence and HF care models, AHA 2026 experts pointed to pharmacists as key to putting new data into practice.
Maximizing pharmacists’ impact on medication safety requires removing barriers to intervention and empowering proactive clinical roles.





